Announcements Trials
Browse Landscape

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Papillomavirus Infections 7Uterine Cervical Neoplasms 5Neuroendocrine Tumors 4Neoplasms 4Autoimmune Diseases 3Ovarian Neoplasms 2Myasthenia Gravis 2Mesothelioma, Malignant 2Lung Neoplasms 2Venous Thrombosis 1Venous Thromboembolism 1Uterine Cervical Dysplasia 1Thyroid Diseases 1Thrombosis 1Squamous Intraepithelial Lesions 1Retinal Telangiectasis 1Renal Insufficiency 1Recurrence 1Prostatic Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Mesothelioma 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphohistiocytosis, Hemophagocytic 1Leukemia, Hairy Cell 1Hemorrhage 1Hematologic Neoplasms 1Glioma 1Glioblastoma 1

Interventions

Metformin 2human papillomavirus vaccine, L1 type 16, 18 1Ultrasonography 1Data Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Abortion, Spontaneous × Data Collection × Clear all
NCT01905462 2013-09-30

Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix Residing in UK

GlaxoSmithKline

Completed
1,046 enrolled

Abortion, Spontaneous, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡